Federal judge casts doubt on 69,000 cases alleging J&J talc caused cancer
Reuters//July 23, 2026//
Summary
- Judge Rukhsanah Singh questions expert testimony on talc causation
- Approximately 69,000 plaintiffs allege J&J talc caused ovarian cancer
- J&J denies talc products contain asbestos or cause cancer
- Plaintiffs must respond by November 19 to avoid dismissal
A federal judge cast doubt on Wednesday on claims by approximately 69,000 people alleging that Johnson & Johnson’s baby powder and other talc products caused ovarian cancer, saying plaintiffs must provide more specific evidence or risk having their lawsuits dismissed.
U.S. Magistrate Judge Rukhsanah Singh in Trenton, New Jersey, said that recent testimony by two of the plaintiffs’ experts raised doubts about whether any plaintiffs can provide evidence admissible in court “that talcum powder use specifically caused her ovarian cancer.”
The two experts, Judith Wolf and Daniel Clarke-Pearson, testified in May in preparation for a set of six “bellwether,” or test, trials for the thousands of cases that have been consolidated in New Jersey’s federal court. Verdicts in bellwether trials are used to assess the potential value of remaining claims and guide settlement talks.
J&J has denied the allegations that its talc products caused cancer, saying that talc was safe and did not contain asbestos.
“Today’s decision brings these cases one step closer inevitable, equitable and appropriate outcome—the complete dismissal of the talc litigation,” J&J’s vice president of litigation, Erik Haas, said in a statement.
A spokesperson for the company did not immediately respond to a request for comment, nor did a lead attorney for the plaintiffs.
Wolf and Clarke-Pearson said they could not completely rule out other possible causes of the plaintiffs’ ovarian cancer, according to Singh’s opinion.
“If such uncertainty is indeed reality, then how can any plaintiff here meet her burden on the merits of her claim?” Singh wrote.
Singh said that the debate over causation would not lead to “instant dismissal” of the thousands of cases in the consolidated federal litigation. The judge ordered plaintiffs to respond by November 19, and to explain why their case should not be dismissed over the failure to provide an admissible expert opinion that J&J talc caused their specific cancer.
In addition to the consolidated federal court cases, J&J also faces lawsuits in state courts around the U.S. J&J has won some of the recent trials in state courts, but juries have awarded large verdicts for plaintiffs in other cases.
The litigation resumed in March 2025, after being put on hold for more than three years during J&J’s repeated failed attempts to resolve the lawsuits through a shell company’s bankruptcy.
J&J stopped selling talc-based baby powder in the U.S. in 2020, switching to a cornstarch product.
Related Articles
Legal Tech
- How ransomware tactics against law firms are changing
- How large language models are leveling the personal injury playing field
- Attorney Share, Lawmatics integrate to automate law firm referrals
Latest Opinion Digests
- Criminal Law-Second-Degree Rape-Sufficiency of Evidence
- Criminal Law-Witness Tampering-Sufficiency of Evidence
- Criminal Law-Post-Conviction Relief-Abandonment by Counsel
- Criminal Law-Filing Criminal Charges-Attorney General Aid
- Criminal Law-Civil Commitment-Sexually Violent Predator
- Criminal Law-Assault-Prosecutorial Misconduct
- Real Property-Prescriptive Easement-Public Right of Way
Top stories
- Missouri Bar committee seeks input on rural legal service gaps
- Appeals court orders new look at conversion therapy case following Supreme Court ruling
- Jury finds seat belt maker liable in $40.5M child injury case
- Injured motorist recovers policy limits, plus medical damages in under a year
- Mother obtains six-figure settlement after rear-end crash leads to lifelong pain
- 8th Circuit affirms denial of preliminary injunction against SB 751
- New dedicated coverage of tech challenges facing law firms and legal departments
- Parity Act claim against insurer for child’s treatment survives motion to dismiss





